July 2, 2020 08:48 AM EDT

Novavax snags Ben Machielse for CMC and promotes a trio of staffers; Marty Duvall lands another CEO post at Oncopeptides

Alex Hoffman

Copy Chief

Kathy Wong

Editor

→ Novavax has been making waves recently by securing a $384 million commitment from CEPI to cover R&D and manufacturing for its Covid-19 vaccine …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Novavax snags Ben Machielse for CMC and promotes a trio of staffers; Marty Duvall lands another CEO post at Oncopeptides

Alex Hoffman

Copy Chief

Kathy Wong

Editor

Sign up to read this article for free.

RFK Jr. and Elon Musk want to ban pharma ads. They wouldn't be the first to try

Jazz wins approval for bispecific in biliary tract cancer

Novartis seeks more bolt-on deals as it purchases neuro startup for up to $1.1B

At Jefferies, all that manufacturers want to talk about is GLP-1s

FDA adcomm raises risk questions on AstraZeneca’s Andexxa

Are programs with compounded GLP-1s safe for your population?

No­vavax snags Ben Machielse for CMC and pro­motes a trio of staffers; Mar­ty Du­vall lands an­oth­er CEO post at On­copep­tides

Copy Chief

Editor

Sign up to read this article for free.

Novavax snags Ben Machielse for CMC and promotes a trio of staffers; Marty Duvall lands another CEO post at Oncopeptides